CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 377 enrolled
Drug / intervention
Non Interventional Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01947894
NCT01947894N/ACompleted
CompareCT.gov

SWEGHO - A PROSPECTIVE NON INTERVENTIONAL STUDY PROTOCOL WITH PRIMARY DATA COLLECTION - ASSESSMENT OF THE LONG TERM TREATMENT OUTCOMES OF GENOTROPIN TREATMENT IN GHD PATIENTS IN SWEDEN

Pfizer·observational·Posted Sep 23, 2013·Updated Nov 20, 2019

In Brief

An observational study evaluating Non Interventional Study for Growth Hormone Deficiency. Completed, enrolled 377 participants across 12 sites.

Detailed Summary

The purpose of this study is to assess the long term treatment outcomes of Growth Hormone treatment in patients who are prescribed and treated with Genotropin. Also, plan to determine the relationships between clinical status, dosage schedule and response to Genotropin treatment. This study will also contribute to our knowledge of adult Growth Hormone Deficiency, including transition period in Childhood Onset Growth Hormone Deficiency and its treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGrowth Hormone Deficiency
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 23, 2013
Enrollment StartNov 20, 2013
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 12.8 years ago

Interventions

Non Interventional Studyother

Non Interventional Study